News
2466 posts · page 61 of 103
Legal Battle Erupts After Surrogate Birth in Texas
A surrogate gave birth amid a legal dispute after refusing to terminate a pregnancy due to a heart defect.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes draft legislation equating devices with drugs, citing potential harm to innovation and investment.
Thermo Fisher Boosts Investments in India Amid Biotech Surge
Thermo Fisher Scientific ramps up investments in India, eyeing growth in biotech and biosimilars as local drugmakers innovate.
Abhay Soi Criticizes Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi challenges the price cap on private hospital rooms, citing investment concerns.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Expansion Plans
Molbio Diagnostics aims to raise ₹940 crore through an IPO to fund capital expenditures and reduce promoter stake.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded a 9.9% stake in Thyrocare Technologies for Rs 986 crore, reducing its holding to 51.02%.
Surrogate Birth Sparks Legal Battle Over Infant's Custody
A surrogate gave birth to a baby diagnosed with a heart defect, igniting a custody dispute.
Medical Device Industry Challenges India’s New Regulatory Bill
India's medical device sector opposes a draft bill treating devices like drugs, citing innovation and investment risks.
Abhay Soi Critiques Proposed Price Cap for Private Hospital Rooms
Max Healthcare's Abhay Soi questions a proposed price cap on private hospital rooms, emphasizing investment needs.
Molbio Diagnostics Aims for ₹940 Crore via IPO: A High-Risk Investment?
Molbio Diagnostics plans to raise ₹940 crore through an IPO, aiming for long-term growth. High-risk investors may find the company's global reach appealing.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloads significant Thyrocare stake, reducing its holding from 60.92% to 51.02%.
Surrogate Faces Custody Battle After Birth Amid Contractual Dispute
A surrogate gave birth in Texas after biological parents sought termination. Now, she seeks custody.
Medical Device Firms Criticize Draft Bill for Pharma-like Regulations
India's medical device sector warns that the Draft Bill's pharma-style regulations could stifle innovation and investment.
Max Healthcare's Abhay Soi Questions Price Cap on Private Hospitals
Abhay Soi argues against a blanket price cap on private hospital rooms, citing investment viability concerns.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics aims to raise ₹940 crore via IPO to boost manufacturing and reduce promoter stake.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloads a 9.9% stake in Thyrocare Technologies, raising Rs 986 crore through bulk and block deals.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate mother fled to Texas to give birth after being asked to terminate the pregnancy due to a heart defect. The child is now with biological parents amid legal disputes.
Medical Device Firms Challenge Draft Bill's Pharma-Like Regulations
India's medical device industry opposes a draft bill treating devices as pharmaceuticals, citing potential harm to innovation and investment.
Abhay Soi Criticizes Proposed Price Caps on Private Hospital Rooms
Max Healthcare's Abhay Soi warns against room rent caps, citing investment concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics plans to raise ₹940 crore through its IPO, with a focus on capital expansion and reducing promoter stake.
Docon Technologies Divests 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore, reducing its holding to 51.02%.
Surrogate Mother Battles for Custody After Texas Birth Amid Dispute
A surrogate mother is fighting for custody after giving birth in Texas, following a dispute with the biological parents over a severe heart defect.
Medical Device Industry Opposes Draft Bill Equating Devices with Pharmaceuticals
India's medical device sector challenges a draft bill that treats devices like drugs, warning it could stifle innovation and investment.
Abhay Soi Criticizes Proposed Cap on Private Hospital Room Rates
Max Healthcare's Abhay Soi urges reconsideration of a price cap on hospital rooms, highlighting investment needs.